Effects of early parenteral supplementation with omega-3 fish oil emulsion on clinical outcome in severe acute pancreatitis

Jiongxin Xiong,Shikai Zhu,Y.U. Zhou

DOI: https://doi.org/10.1016/j.jamcollsurg.2009.06.111

2009-01-01

Journal of the American College of Surgeons

Abstract:Journal of the American College of Surgeons 209(3):p S47-S48, September 2009. | DOI: 10.1016/j.jamcollsurg.2009.06.111

What problem does this paper attempt to address?

The value of parenteral fish off lipid emulsion supplementation combined with early enteral nutritional support in patients after pancreatoduodenectomy

Xin-hua ZHU,Ya-fu WU,Yu-dong QIU,Jian-xin ZHOU,Chun-ping JIANG,Yi-tao DING

DOI: https://doi.org/10.3969/j.issn.1007-810X.2011.06.008

2011-01-01

Abstract:Objective: The effect of parenteral fish oil lipid emusion supplementation combined with early enteral nutritional support on pancreatoduodenectomy was investigated with a randomized,controlled clinical trial.Methods: Seventy six patients were randomly divided into two groups:fish oil lipid group(n=38) and control group(n=38).Patients in fish oil lipid group received parenteral fish oil lipid emusion supplementation combined with early enteral nutritional support for five days after pancreatoduodenectomy.Venous blood samples were obtained for assay on the day before surgery and day 6 after surgery.Results: Compared with the results of control group,a significant difference was seen in the extent of decrease of body weight,albumin and prealbumin in fish oil lipid group(P<0.05).ALT、AST and LDH were significantly decreased on day 6 in fish oil lipid group(P<0.01),and a significant difference was seen in the extent of decrease of ALT、AST and LDH in fish oil lipid group(P<0.05).No significant difference of total bilirubin and direct bilirubin was seen in both groups.There were 4 cases with infective complication in fish oil lipid group,and 8 cases in control group.Compared with control group,a significant decrease of postoperative hospital stay was observed in fish oil lipid group.Conclusion: The parenteral fish oil lipid emusion supplementation combined with early enteral nutritional support can greatly improve nutrition states and liver function of patients,and it is of great importance in patients received pancreatoduodenectomy.
The Effect of Ω-3 Polyunsaturated Fatty Acid on Inflammatory Response and Systemic Disease Sequelae in Severe Acute Pancreatitis Patients

WANG Xin-ying,LI Wei-qin,LI Ning,LI Jie-shou

DOI: https://doi.org/10.3969/j.issn.1007-810x.2008.04.006

2008-01-01

Abstract:Objective: To investigate whether ω-3 fatty acid supplementation affects inflammatory response and systemic disease sequelae in severe acute pancreatitis patients.Methods: Forty severe acute pancreatitis patients were prospectively enrolled and were randomly assigned to receive total parenteral nutrition(TPN) for 5 days in a double-blinded manner with either soybean oil(SO) or fish oil(FO) supplementation.Serum concentrations of EPA、IL-6、C reactive protein and white blood cell were measured before TPN and on the sixth day after starting TPN.The vital signs during the TPN infusion were recorded.Routine respiratory and renal parameters were monitored to assess the systemic response at the organ level.Results: Patients treated with ω-3 FA had significantly higher EPA concentration,lower CRP level and better oxygenation index during the observation period.The level of IL6 was decreased on the sixth day after TPN in the study group.Although there was no significant difference between two groups,the ratio of infection,length of ICU and hospital day had a trend to decrease in the study group.Conclusion: TPN supplemented with ω-3 FA diminishes inflammatory response and systemic disease sequelae in SAP patients.This together with improved respiratory and renal function suggests that the systemic response to pancreatic injury is attenuated.
Clinical Effect of Multi-Oil Fat Emulsion for Parenteral Nutrition Support in Extremely Low Birth Weight Infants

Hui-Jia Lin,Xiao-Xia Shen,Ying-Hua Ni,Xiao-Lu Ma,Li-Ping Shi,Li-Zhong DU

DOI: https://doi.org/10.7499/j.issn.1008-8830.2011029

2021-01-01

Abstract:OBJECTIVE:To study the clinical effect of multi-oil fat emulsion for parenteral nutrition support in extremely low birth weight (ELBW) infants. METHODS:A retrospective analysis was performed for 49 ELBW infants who were admitted from January 1, 2018 to July 30, 2020, with an age of ≤14 days on admission and a duration of parenteral nutrition of > 14 days. According to the type of lipid emulsion received, the ELBW infants were divided into two groups: soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) (n=26) and medium-chain triglycerides/long-chain triglycerides (MCT/LCT) (n=23). The two groups were compared in terms of clinical features, complications, nutrition support therapy, and outcome. RESULTS:The 49 ELBW infants had a mean birth weight of (892±83) g and a mean gestational age of (28.2±2.3) weeks. There was no significant difference between the two groups in the incidence rates of hemodynamically significant patent ductus arteriosus, intraventricular hemorrhage, neonatal necrotizing enterocolitis, retinopathy of prematurity, bronchopulmonary dysplasia (BPD), grade Ⅲ BPD, sepsis, and pneumonia (P > 0.05). There was also no significant difference in the duration of parenteral nutrition, the age of total enteral nutrition, and head circumference/body length/body weight at discharge between the two groups (P > 0.05). Of all the infants, 22 (45%) had parenteral nutrition-associated cholestasis (PNAC), with 13 (50%) in the SMOF group and 9 (39%) in the MCT/LCT group but there was no significant difference in the incidence of PNAC between the two groups (P > 0.05); however, the infants with PNAC in the SMOF group had significantly lower peak values of direct bilirubin and alanine aminotransferase than those in the MCT/LCT group (P < 0.05). CONCLUSIONS:The application of multi-oil fat emulsion in ELBW infants does not reduce the incidence rate of complications, but compared with MCT/LCT emulsion, SMOF can reduce the severity of PNAC in ELBW infants.
Effects of different postoperative nutritional support on oxidative stress and clinical outcomes for patients after gastrointestinal surgery

YAO Yushi,WANG Lei

DOI: https://doi.org/10.3969/j.issn.1004-3594.2011.09.015

2011-01-01

Abstract:Objective To evaluate the effect of different postoperative nutritional support on oxidative stress and clinical outcomes for patients after gastrointestinal surgery.Methods Sixty patients undergoing gastrointestinal neoplasm radical surgery were randomly divided into two groups:parenteral nutrition(PN) group and parenteral nutrition combined with enteral nutrition(PN + EN) group,30 cases in each group.Basic conditions,nutrition status,oxidative stress indices and clinical outcomes were compared.Results BMI in both groups was significantly decreased one week after surgery(P<0.05 ).There was no significant difference in concentrations of ALB and PA between the two groups after operation.The concentration of HGB and lymphocytes in the PN group was significantly decreased one week after surgery(P<0.05) while the concentration of HGB in the PN + EN group was not significantly different but lymphocytes were significantly increased(P<0.05).SOD activities were significantly increased in both groups one week after surgery(P<0.05).GSH activity in the PN group was significantly decreased(P<0.05);but was significantly increased in the PN + EN group(P<0.05).MDA content in the TPN group was significantly increased one week after surgery(P<0.05 ),but decreased significantly in the PN + EN group(P<0.05).The recovery time of anal passing flatus,postoperative hospital stay and cost of nutrition treatment in the PN + EN group patients were well below those in the PN group(P<0.05).The complication rate was decreased compared with the PN group,though not significantly(P>0.05).Conclusions PN + EN improves the ability against the postoperative oxidative stress and clinical outcomes,so it can be the first choice for nutritional support in patients undergoing gastrointestinal surgery.
An Observational Study of the Effects of Ω-3 Polyunsaturated Fatty Acid-Supplemented Parenteral Nutrition on Postoperative Complications in Patients with Crohn's Disease.

Yu Shen,Huaying Liu,Weilin Qi,Wei Liu,Lingna Ye,Qian Cao,Xiaolong Ge,Wei Zhou

DOI: https://doi.org/10.21037/apm-22-948

2023-01-01

Annals of Palliative Medicine

Abstract:BACKGROUND:Crohn's disease (CD) is a chronic inflammatory disease. Most patients with CD require surgery but exhibit an elevated incidence of postoperative complications. Omega-3 polyunsaturated fatty acids (ω-3 PUFAs) are considered beneficial for nutrition, anti-inflammation, immunity, and intestinal microflora balance in humans. This study assessed the effects of ω-3 PUFA-supplemented parenteral nutrition (PN) on postoperative complications in CD patients.METHODS:Overall, 186 CD patients undergoing bowel resection were recruited for this study. The patient data were collected from a prospectively maintained database. After surgery, 83 patients received ω-3 PUFA-supplemented PN, and 103 did not. The postoperative complications were compared between the groups. Complication risk factors were identified by univariate and multivariate analyses.RESULTS:Patients who received ω-3 PUFA-supplemented PN after surgery had lower C-reactive protein (CRP) levels on postoperative day 3 (57.2±5.3 vs. 43.5±3.9 mg/L, P=0.047) and shorter postoperative hospital stays (12.1±1.1 vs. 9.3±0.6 days, P=0.041) than those who did not. The ω-3 PUFA group exhibited significantly fewer overall complications (40.8% vs. 24.1%, P=0.016) and major complications (23.3% vs. 9.6%, P=0.014) than the control group. Postoperative complications were associated with infliximab, ω-3 PUFAs, CRP levels, operative time, and laparoscopic surgery. The multivariate regression revealed that preoperative infliximab use was a positive risk factor and postoperative ω-3 PUFA-supplemented PN was a negative risk factor for postoperative complications.CONCLUSIONS:ω-3 PUFA-supplemented PN reduced post-surgery inflammatory response of CD patients, which in turn decreased the postoperative complications and accelerated recovery.
ω-3 fatty acids - Supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: A randomized and controlled study

xinying wang,weiqin li,ning li,jieshou li

DOI: https://doi.org/10.1177/0148607108316189

2008-01-01

Journal of Parenteral and Enteral Nutrition

Abstract:Background: The objective of this study was to investigate whether altering the fatty acid (FA) profile by omega-3 FA supplementation affects inflammatory response and systemic disease sequelae in severe acute pancreatitis. Methods: Forty severe acute pancreatitis patients were enrolled and randomly assigned to receive parenteral nutrition (PN) 1 or 5 days in a double-blind manner. Patients received PN with identical amounts of amino acids (1.25 g/kg/d), glucose (3 g/kg/d), and fat (1 g/kg/d) but different lipid compositions: the control group received a soybean oil (SO; Lipovenos 20%; Fresenius, Germany)-based fat solution and the omega-3 FA group was supplemented with 0.15 - 0.2 g/kg/d fish oil (FO; Omegaven 10%; Fresenius, Germany). Serum concentrations of eicosapentaenoic acid (EPA), interleukin-6, C-reactive protein (CRP), white blood cell count, and routine respiratory and renal parameters were measured before PN, and again on day 6 after starting PN Outcomes such as infection morbidity, mortality. intensive care unit time, and length of hospital stay were recorded. Results: Patients treated with FO. had a significantly higher EPA concentration (P < .01), lower CRP level (P < .05), and better oxygenation index (P < .05) after 5 days of PN. Moreover, the number of days of continuous renal replacement therapy (CRRT) in the omega-3 FAs group was significantly less than that in the control group (P < .05). Conclusions: PN supplemented with omega-3 FAs diminishes the hyperinflammatory response by the EPA increase and the proinflammatory cytokine decrease in severe acute pancreatitis. This, together with improved respiratory function and shortened CRRT time, suggests that the systemic response to pancreatic and organ injury is attenuated.
The Effect of Ω-3 Polyunsaturated Fatty Acid on Immune Function, Infection and Surgery Ratio in Severe Acute Pancreatitis Patients

Xin-ying WANG,Li-ya PAN,Wei-qin LI,Ning LI

DOI: https://doi.org/10.3969/j.issn.1007-810x.2009.06.001

2009-01-01

Abstract:Objective: To investigate whether ω-3 fatty acid supplementation affects immune function, infection and surgery ratio in severe acute pancreatitis patients. Methods: Fifty-six severe acute pancreatitis patients were prospectively enrolled and were randomly assigned to receive total parenteral nutrition (TPN) for 5 days in a double-blinded manner with either soybean oil (SO) or fish oil (FO) supplementation. The level of IL-10 and HLA-DR expression were measured before TPN and on the sixth day after starting TPN. The clinical outcomes such as infection and surgery ratio were recorded. Results % Patients treated with ω-3 FA had significantly higher IL-10 concentration and better HLA-DR expression during the observation period. Although there was no significant difference between two groups, the ratio of infection and surgery ratio had a trend to decrease in the study group. Conclusion: TPN supplemented with ω-3 FA improves anti-inflammatory cytokine and immune function in SAP patients. It also leads to the attenuated risk of infection and surgery ratio.
Effects of Ω‐3 Fish Oil Lipid Emulsion Combined with Parenteral Nutrition on Patients Undergoing Liver Transplantation

Xinhua Zhu,Yafu Wu,Yudong Qiu,Chunping Jiang,Yitao Ding

DOI: https://doi.org/10.1177/0148607112440120

2012-01-01

Abstract:Background: The effect of parenteral nutrition (PN) support supplemented with omega-3 fatty acids was investigated in a randomized, controlled clinical trial at the Affiliated Drum Tower Hospital, Medical School of Nanjing University. Materials and Methods: Ninety-eight patients with the diagnosis of end-stage liver disease or hepatic cellular carcinoma were admitted for orthotopic liver transplantation at the Affiliated Drum Tower Hospital. The patients were randomly divided into 3 groups: diet group (n = 32), PN group (n = 33), and polyunsaturated fatty acid (PUFA) group (n = 33). Patients in the PN and PUFA groups received isocaloric and isonitrogenous PN for 7 days after surgery. Venous heparin blood samples were obtained for assay on days 2 and 9 after surgery. A pathological test was performed after reperfusion of the donor liver and on day 9. Results: Alanine aminotransferase levels were improved significantly by PUFA treatment compared with traditional PN support (P < .05). Compared with the results on day 9 in the PN group, a significant difference was seen in the extent of increase of the prognostic nutrition index and prealbumin in the PUFA group. The pathological results also showed that omega-3 fatty acid supplementation reduced hepatic cell injury. PUFA therapy also decreased the incidence of infectious morbidities and shortened the posttransplant hospital stay significantly. Conclusion: Posttransplant PN support can greatly improve metabolism of protein and nutrition states of patients. omega-3 fatty acid-supplemented PN significantly reduces injury of the transplanted liver, decreases the incidence of infectious morbidities, and shortens posttransplant hospital stay. (JPEN J Parenter Enteral Nutr. 2013;37:68-74)
Effect of Parenteral Fish Oil Lipid Emulsion in Parenteral Nutrition Supplementation Combined with Enteral Nutrition Support in Patients Undergoing Pancreaticoduodenectomy

Xinhua Zhu,Yafu Wu,Yudong Qiu,Chunping Jiang,Yitao Ding

DOI: https://doi.org/10.1177/0148607112450915

2012-01-01

Abstract:BACKGROUND:The effect of parenteral fish oil lipid emulsion in parenteral nutrition (PN) supplementation combined with enteral nutrition (EN) support on pancreaticoduodenectomy (PD) was investigated with a randomized controlled clinical trial at the Affiliated Drum Tower Hospital.MATERIALS AND METHODS:Seventy-six patients who underwent PD in the Department of Hepatobiliary Surgery were randomly divided into 2 groups: the polyunsaturated fatty acid (PUFA) group (n = 38) and control group (n = 38). Patients in the PUFA group received parenteral fish oil lipid emulsion supplementation combined with early EN support for 5 days after PD. Venous blood samples were obtained for assay on the day before surgery and on day 6 after surgery.RESULTS:Compared with the results of the control group, a significant difference was seen in the extent of the decrease in total protein and prealbumin in the PUFA group (P < .05). Alanine aminotransferase (ALT), aspartate aminotransferase (AST), and lactate dehydrogenase (LDH) were significantly decreased on day 6 in the PUFA group (P < .01), and a significant difference was seen in the extent of decrease in ALT, AST, and LDH in the PUFA group (P < .05). The ratio of infectious complications in the PUFA group was significantly decreased, as well as the postoperative hospital stay (P < .05), and there was no hospital mortality in this study.CONCLUSION:Parenteral fish oil lipid emulsion in PN supplementation combined with EN support can greatly improve the nutrition state and liver function of patients, decrease the incidence of infectious morbidities, and shorten the postoperative hospital stay.
The Efficacy of Parenteral Fish Oil in Critical Illness Patients with Sepsis: a Prospective, Non-Randomized, Observational Study

Wen-si Li,Zhang-zhang Chen,Yi-jun Zheng,Ming Zhong,Jie-fei Ma,Li-zhen Xuan,Jie-qiong Song,Qian-zhou Lv,Du-ming Zhu

DOI: https://doi.org/10.6133/apjcn.032017.07

2018-01-01

Abstract:BACKGROUND AND OBJECTIVES:To investigate the clinical outcomes in septic patients receiving parenteral fish oil.METHODS AND STUDY DESIGN:A prospective, non-randomized, observational clinical study was carried out in 112 patients with sepsis from March, 2013 to May, 2015 in the surgical intensive care unit (SICU) of a tertiaryreferral hospital. The patients were put into one of two groups; either the control or the study group. Patients received the standard treatment of sepsis based on guidelines in the control group. In the study group, patients received parenteral nutrition (PN) containing fish oil. The Acute Physiology and Chronic Health Evaluation II (APACHE II) scores, the length of ICU and hospital stay, duration of mechanical ventilation, mortality, and readmission into the ICU were recorded. Tumor necrosis factor (TNF)-α and procalcitonin (PCT) levels were also evaluated.RESULTS:The study group showed a significant reduction for all-cause mortality (20.0% vs 10.0% in study and control groups, p=0.034) and APACHE II score on day 5 (p=0.015), day 7 (p=0.036) and day out of SICU (p=0.045) compared with the control group. The study group tended to show a shortened length of stay in the ICU compared to the control group. However, TNF-α and PCT level, 28 d mortality, the length of hospital stay and the duration of mechanical ventilation did not show statistical differences between the two groups. There were no drug-related adverse effects shown during the study.CONCLUSIONS:PN with fish oil is probably safe and may improve clinical outcome in critical ill patients with sepsis.
Fish Oil-Supplemented Parenteral Nutrition in Severe Acute Pancreatitis Patients and Effects on Immune Function and Infectious Risk: A Randomized Controlled Trial

Xinying Wang,Weiqin Li,Feng Zhang,Liya Pan,Ning Li,Jieshou Li

DOI: https://doi.org/10.1007/s10753-009-9136-0

2009-01-01

Inflammation

Abstract:The human leukocyte antigen (HLA)-DR expression on monocytes and plasma Interleukin (IL)-10 levels are key indicators of immune response during the acute phase of severe acute pancreatitis (SAP). We designed a pilot study to investigate whether omega-3 fatty acids (FAs) supplemented parenteral nutrition (PN) could improve immune response in SAP patients. Fifty-six SAP patients were enrolled (28 patients in each group) and received isocaloric and isonitrogenous parenteral nutrition, providing 1.0 g/kg/day standard soybean-oil based fat (omega-6 FAs group) or 0.8 g/kg/day soybean oil +0.2 g/kg/day omega-3 FAs based fat (omega-3 FAs group). IL-10, HLA-DR and the ratio of CD4(+) to CD8(+) were determined before PN treatment and on day 6 after starting PN. The infection and surgery rates were recorded until hospital discharge. A significant IL-10 increase was associated with the administration of omega-3 FAs (p = 0.04, vs omega-6 FAs group). Monocyte HLA-DR expression improved in both groups after 5 days of PN treatment. This increase was significantly higher in the omega-3 FAs group compared to omega-6 FAs (p = 0.01). There was no significant difference of CD4(+)/CD8(+), infection and surgery rates between the two groups. In conclusion, omega-3 FAs supplemented PN can elevate the IL-10 level and HLA-DR expression in SAP patients. A larger trial is required to see whether omega-3 FAs supplemented PN treatment in SAP patients would result in better clinical outcomes than omega-6 FAs.
Liver-protecting Effects of Omega-3 Fish Oil Lipid Emulsion in Liver Transplantation

Xin-Hua Zhu,Ya-Fu Wu,Yu-Dong Qiu,Chun-Ping Jiang,Yi-Tao Ding

DOI: https://doi.org/10.3748/wjg.v18.i42.6141

IF: 5.374

2012-01-01

World Journal of Gastroenterology

Abstract:AIM:To investigate the liver-protecting effect of parenteral nutrition（PN） support with omega-3 fatty acids in a randomized controlled clinical trial.METHODS:Sixty-six patients with the diagnosis of end-stage liver disease or hepatic cellular carcinoma were admitted to the Affiliated Drum Tower Hospital,Nanjing University,China for orthotopic liver transplantation.The patients were randomly divided into two groups:PN group（n = 33） and polyunsaturated fatty acid（PUFA） group（n = 33）.All patients received isocaloric and isonitrogenous PN for seven days after surgery,and in PUFA group omega-3 fish oil lipid emulsion replaced part of the standard lipid emulsion.Liver function was tested on days 2 and 9 after surgery.Pathological examination was performed after reperfusion of the donor liver and on day 9.Clinical outcome was assessed based on the post-transplant investigations,including:（1） post-transplant mechanical ventilation;（2） total hospital stay;（3） infectious morbidities;（4） acute and chronic rejection;and（5） mortality（intensive care unit mortality,hospital mortality,28-d mortality,and survival at a one-year post-transplant surveillance period）.RESULTS:On days 2 and 9 after operation,a significant decrease of alanine aminotransferase（299.16 U/L ± 189.17 U/L vs 246.16 U/L ± 175.21 U/L,P = 0.024） and prothrombin time（5.64 s ± 2.06 svs 2.54 s ± 1.15 s,P = 0.035） was seen in PUFA group compared with PN group.The pathological results showed that omega-3 fatty acid supplement improved the injury of hepatic cells.Compared with PN group,there was a significant decrease of post-transplant hospital stay in PUFA group（18.7 d ± 4.0 d vs 20.6 d ± 4.6 d,P = 0.041）.Complications of infection occurred in 6 cases of PN group（2 cases of pneumonia,3 cases of intra-abdominal abscess and 1 case of urinary tract infection）,and in 3 cases of PUFA group（2 cases of pneumonia and 1 case of intra-abdominal abscess）.No acute or chronic rejection and hospital mortality were found in both groups.The one-year mortality in PN group was 9.1%（3/33）,one died of pulmonary infection,one died of severe intra-hepatic cholangitis and hepatic dysfunction and the other died of hepatic cell carcinoma recurrence.Only one patient in PUFA group（1/33,3.1%） died of biliary complication and hepatic dysfunction during follow-up.CONCLUSION:Post-transplant parenteral nutritional support combined with omega-3 fatty acids can significantly improve the liver injury,reduce the infectious morbidities,and shorten the post-transplant hospital stay.
Impact of Short-Term Omega-3 Fatty Acids Supplementation on Clinical Outcomes in Postoperative Patients with Parenteral Nutrition Support: a Meta-analysis of Randomized Controlled Trials

ZHANG Yan-wu,JIANG Zhu-ming,WANG Yang,ZHU Ming-wei,Wang Yan

DOI: https://doi.org/10.3760/cma.j.issn.1674-635x.2011.04.001

2011-01-01

Abstract:Objective To evaluate the impact of omega-3 fatty acids intervention on clinical outcomes in postoperative patients with parenteral nutrition (PN). Methods Literatures relating to the evaluation of the clinical outcomes after supplementation with omega-3 fatty acids after selective surgeries were searched in databases including PubMed, EMBASE, Cochrane Library, Web of Science, Chinese Biomedical Databases, China National Knowledge Infrastructure, and Wanfang Database etc. All the eligible studies were randomized controlled trials and their results were published from January 1996 to June 2010. The methodological quality was assessed using Jadad scale, Schulz allocation concealment tool, and methodology review. Meta analysis was conducted using RevMan 5.1 software. The impact was described in terms of complications of infection, case-fatality rate, length of postoperative hospital stay, and length of postoperative ICU stay. Results Totally 320 articles were found and 17 randomized controlled trials ( n =1213 ) entered final meta analysis study. The results showed a significant decrease in the infectious complication rates of postoperative patients receiving omega-3 fatty acids intervention [risk ratio (RR) =0.44, 95％ confidence interval (CI) (0.30, 0.64), P ＜0.0001] ; meanwhile, the length of hospital stay was significantly shortened [mean difference (MD) =- 1.65 ; 95％ CI ( - 2.72, - 0.58), P =0.003]. However,the length of ICU stay showed no significant difference [MD =-0.31,95％ CI ( - 1.20, 0.58), P =0.500].Conclusion Omega-3 fatty acids interventions can benefit postoperative patients by reducing the morbidity of postoperative infectious complications and shortening the length of hospital stay.
Effect of postoperative early ω-3 polyunsaturated fatty acid-based total parenteral nutrition on postoperative complications for patients with Crohn′s disease

葛晓龙,唐莎莎,刘威,戚卫林,叶玲娜,曹倩,周伟,张敏,古敏怡

DOI: https://doi.org/10.3760/cma.j.issn.2096-367X.2020.01.008

2020-01-01

Abstract:Objective To investigate the effect of postoperative early ω-3 polyunsaturated fatty acid-based total parenteral nutrition (TPN) on postoperative complications for patients with Crohn's disease (CD).Methods Clinical data of 186 CD patients undergoing intestine resection at Department of General Surgery in our hospital between January 2017 and May 2018 were retrospectively analyzed.The perioperative data and laboratory data were compared between patients with and without ω-3 polyunsaturated fatty acid-based TPN (TPN with ω-3 group and TPN without ω-3 group).Meanwhile CD patients were divided into two groups:103 patients in without complications group and 83 patients in with complications group.Univariate and multivariate logistic regression analyses were performed to identify the risk factors for postoperative complications.Results As compared to TPN without ω-3 group,TPN with ω-3 group presented lower postoperative C-reactive protein (CRP) level [(43.5 ± 3.9) mg/L vs.(57.2 ± 5.3) mg/L,P =0.047],lower morbidity of overall postoperative complication (24.1％ vs.40.8％,P =0.016),lower morbidity of severe complications (9.6％ vs.23.3％,P =0.014),shorter postoperative hospital stay [(9.3 ± 0.6) d vs.(12.1 ± 1.1) d,P =0.041].Univariate analysis showed preoperative use of infliximab,TPN with ω-3 polyunsaturated fatty acid,CRP,operative time,and laparoscopic surgery were associated with complications (all P＜0.05).Multivariate analysis revealed that preoperative use of infliximab and postoperative TPN with ω-3 polyunsaturated fatty acid were independent risk factor and protective factor respectively of postoperative complications for CD patients.Conclusion The inflammation ameliorates in CD patient with ω-3 polyunsaturated fatty acid-based TPN after surgery,leading to the decrease of postoperative complications and the acceleration of recovery of patients.
Cost and Effectiveness of Omega-3 Fatty Acid Supplementation in Chinese ICU Patients Receiving Parenteral Nutrition

Guo Hao Wu,Jian Gao,Chun Yan Ji,Lorenzo Pradelli,Qiu Lei Xi,Qiu Lin Zhuang

DOI: https://doi.org/10.2147/ceor.s81277

2015-01-01

ClinicoEconomics and Outcomes Research

Abstract:Background and objectives Clinical evidence supports the use of omega-3 polyunsaturated fatty acid (PUFA)-enriched lipid emulsions in place of standard lipid emulsions in parenteral nutrition (PN) for intensive care unit (ICU) patients, but uptake may be limited by higher costs. We compared clinical and economic outcomes for these two types of lipid emulsion in the Chinese ICU setting. Methods We developed a pharmacoeconomic discrete event simulation model, based on efficacy data from an international meta-analysis and patient characteristics, resource consumption, and unit costs from a Chinese institutional setting. Probabilistic sensitivity analyses were undertaken to assess the effects of uncertainty around input parameters. Model predictive validity was assessed by comparing results with data observed in a patient subset not used in the modeling. Results The model predicted that omega-3 PUFA-enriched emulsion (Omegaven® 10% fish oil emulsion) would dominate standard lipid emulsions, with better clinical outcomes and lower overall health care costs (mean savings ~10,000 RMB), mainly as a result of faster recovery and shorter hospital stay (by ~6.5 days). The external validation process confirmed the reliability of the model predictions. Conclusion Omega-3 PUFA-enriched lipid emulsions improved clinical outcome and decreased overall costs in Chinese ICU patients requiring PN.
The Impact of Fish Oil (Ω-3 Fatty Acids) Intervention on Infectious Complications and Cost-Effectiveness for Postoperative Patients: Systematic Review (2010-2016)

Li Xiaoxiao,Jiang Zhuming,Zhai Suodi,Dong Chaoran,Zhu Mingwei

DOI: https://doi.org/10.3760/cma.j.issn.1674-635x.2016.06.001

2016-01-01

Abstract:Objective To evaluate the impact of fish oil (ω-3 fatty acids) parenteral nutrition (PN) on outcomes for non-ICU postoperative patients.Methods PubMed,Embase,Cochrane,China National Knowledge Infrastructure (CNKI) and Wanfang Database etc.were searched to retrieve the eligible studies published from January 2010 to June 2016.The studies included were randomized controlled trials (RCTs) that evaluated the effects of supplementation of fish oil (Omegawen) in PN regimens for postoperative patients on clinical outcomes.The methodological quality assessment was based on Jadad scale and Schulz allocation concealment tool.Meta-analysis was conducted by RevMan 5.3 software.Results 19 RCTs,1 170 surgical patients,were included.Meta-analysis indicated that short-term fish oil supplementation significantly reduced the incidence of infectious complications [RR =0.44,95％ CI (0.31,0.64),P ＜0.000 1] and shortened the length of hospital stay [MD =-0.85,95％ CI (-1.67,-0.03),P=0.04],while with no significant effect on mortality [RR =0.42,95％ CI (0.07,2.63),P =0.36] and total expenditure of hospitalization [MD =-216.60,95％ CI (-718.94,285.75),P =0.40].Sensitivity analysis showed similar results.Conclusion According to existing evidence,fish oil in PN for surgical patients could reduce the incidence of postoperative infectious com-plications and shorten the length of hospital stay.
Early Peritoneal Lavage with Ulinastatin Improves Outcome and Enhances Multi-Organ Protection in a Model of Severe Acute Pancreatitis.

Cong Feng,Xuan Su,Xuan Zhou,Li-Li Wang,Bei Li,L I Chen,Fa-Qin Lv,Tan-Shi Li

DOI: https://doi.org/10.3892/etm.2015.2251

IF: 2.7

2015-01-01

Experimental and Therapeutic Medicine

Abstract:The aim of this study was to investigate the effect of early peritoneal lavage with ulinastatin on the outcome of a rat model of severe acute pancreatitis (SAP). A total of 80 male Wistar rats were randomly divided into the following groups: Sham-operated (C), SAP model (M), saline lavage (SL), intravenous ulinastatin (IU), early ulinastatin lavage (EUL) and late ulinastatin lavage (LUL). Intraperitoneal lavage or injection were performed immediately subsequent to the establishment of the SAP model in groups SL, IU and EUL and 3 h later in group LUL. Intraperitoneal lavage with or without ulinastatin was performed for 3 h. The survival time of the rats in groups C, M, EUL and LUL was recorded over a 12-h period and the median survival time was calculated. At 3 h after the induction of SAP, histopathological analyses were performed and the biochemical parameters of groups C, M, SL, IU and EUL were assessed. Groups EUL and LUL exhibited an increased median survival time compared with Group M, with the survival time of the rats in group EUL markedly longer than that in the group LUL rats. Group SL, IU and EUL rats were found to have reduced plasma activities of amylase, lipase, aspartate transaminase and alanine transaminase, with the biggest change observed in the group EUL rats. Furthermore, the intervention in groups SL and EUL was more effective at reducing creatinine and urea levels than that in group IU. Rats in group EUL exhibited a greater inhibition of the SAP-induced increase in troponin T levels than rats in groups SL and IU. The pathological severity scores of the pancreas, liver, kidney and lung in group EUL were significantly lower than those in groups M and better than those in groups SL and IU. In conclusion, early intraperitoneal lavage with ulinastatin significantly improves the median survival time and protects multi-organ function in an SAP model.
IMR880760 Supplemetal Material - Supplemental Material for Effect of Regional Arterial Infusion Combined with Early Enteral Nutrition on Severe Acute Pancreatitis

Xiaojuan Wang,Jinbu Xu,Ji‐Guang Li,Yajuan Cheng,Lu Liu,Zhiqiang Du

DOI: https://doi.org/10.25384/sage.10101626.v1

2019-01-01

Abstract:Supplemental material, IMR880760 Supplemetal Material for Effect of regional arterial infusion combined with early enteral nutrition on severe acute pancreatitis by Xiaojuan Wang, Jinbu Xu, Jiguang Li, Yajuan Cheng, Lu Liu and Zhiqiang Du in Journal of International Medical Research
The Role of Omega-3 Fatty Acids in Acute Pancreatitis: A Meta-Analysis of Randomized Controlled Trials

Qiu Cheng Lei,Xin Ying Wang,Xian Feng Xia,Hua Zhen Zheng,Jing Cheng Bi,Feng Tian,Ning Li

DOI: https://doi.org/10.3390/nu7042261

IF: 5.9

2015-01-01

Nutrients

Abstract:To determine whether treatment with omega-3 fatty acids (ω-3 FA) provides benefits to patients with acute pancreatitis (AP). The Cochrane Library, PubMed, Embase, Web of Science, and Chinese Biomedical Literature Database were searched. Data analysis was performed using Revman 5.2 software. A total of eight randomized controlled trials (RCTs) were included. Overall, ω-3 FA treatment resulted in a significantly reduced risk of mortality (RR 0.35; 95% CI 0.16 to 0.75, p < 0.05), infectious complications (RR 0.54; 95% CI 0.34 to 0.85, p < 0.05) and length of hospital stay (MD -6.50; 95% CI -9.54 to -3.46, p < 0.05), but not length of ICU stay (MD -1.98; 95% CI -6.92 to 2.96, p > 0.05). In subgroup analysis, only patients who received ω-3 FA parenterally had some statistically significant benefits in terms of mortality (risk ratio (RR) 0.37; 95% confidence interval (CI) 0.16 to 0.86, p < 0.05), infectious complications (RR 0.5; 95% CI 0.28 to 0.9, p < 0.05) and length of hospital stay (mean difference (MD) -8.13; 95% CI -10.39 to -5.87, p < 0.001). The administration of ω-3 FA may be beneficial for decreasing mortality, infectious complications, and length of hospital stay in AP, especially when used parenterally. Large and rigorously designed RCTs are required to elucidate the efficacy of parenteral or enteral ω-3 FA treatment in AP.
Omega‐3 fatty acid lipid emulsions are safe and effective in reducing endotoxemia and sepsis in acute‐on‐chronic liver failure: An open‐label randomized controlled trial

Anand V Kulkarni,Lovkesh Anand,Ashish Kumar Vyas,Madhumita Premkumar,Ashok K Choudhury,Nirupama Trehanpati,Jaya Benjamin,Guresh Kumar,Yogendra Kumar Joshi,Shiv Kumar Sarin

DOI: https://doi.org/10.1111/jgh.15400

2021-01-28

Journal of Gastroenterology and Hepatology

Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background and aim</h3><p>Sepsis is an important determinant of the outcome of acute‐on‐chronic liver failure (ACLF) patients. Omega‐3 fatty acids (FAs) are known to suppress inflammation, reduce morbidity, and mortality in postoperative and critically ill patients. We aimed to evaluate the effect of intravenous omega‐6 and omega‐3 FA lipid emulsions in ACLF patients.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Ninety ACLF patients were randomly allocated to 3 groups‐ Gr. A‐ received no lipid emulsions, Gr. B‐ omega‐6 FAs, and Gr. C‐ omega‐3 FAs. The primary and secondary aims were to compare the effects of lipid emulsions on immune modulation, the incidence of bacterial sepsis, and mortality at day‐28.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The baseline characteristics of the patients were comparable. Serum endotoxin levels remained suppressed by 22% in Gr. C compared with a 4% and 12% rise in Gr. B and A (<i>p</i><0.001). Omega‐3 FAs also suppressed C‐reactive protein levels and neutrophil‐to‐lymphocyte ratio in Gr. C. Compared with Gr. A, omega‐3 FAs reduced sepsis by 86% (HR‐0.14(95%CI, 0.04‐0.43; <i>p</i><0.001). Omega‐3 FAs significantly increased the expression of TLR2 and TLR4 on both CD14+ and CD16+ monocytes, and TLR4, on macrophages and neutrophils. There were no serious adverse events, except transient flushing in 20% and 16.6% of patients receiving omega‐6 FAs and omega‐3 FAs, respectively. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>Omega‐3 FAs are safe and effective in reducing systemic inflammation, endotoxemia, and sepsis in patients with ACLF. These lipid emulsions could also be considered as effective sources of immunonutrition in such sick patients.</p></section>

gastroenterology & hepatology

Effects of early parenteral supplementation with omega-3 fish oil emulsion on clinical outcome in severe acute pancreatitis

The value of parenteral fish off lipid emulsion supplementation combined with early enteral nutritional support in patients after pancreatoduodenectomy

The Effect of Ω-3 Polyunsaturated Fatty Acid on Inflammatory Response and Systemic Disease Sequelae in Severe Acute Pancreatitis Patients

Clinical Effect of Multi-Oil Fat Emulsion for Parenteral Nutrition Support in Extremely Low Birth Weight Infants

Effects of different postoperative nutritional support on oxidative stress and clinical outcomes for patients after gastrointestinal surgery

An Observational Study of the Effects of Ω-3 Polyunsaturated Fatty Acid-Supplemented Parenteral Nutrition on Postoperative Complications in Patients with Crohn's Disease.

ω-3 fatty acids - Supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: A randomized and controlled study

The Effect of Ω-3 Polyunsaturated Fatty Acid on Immune Function, Infection and Surgery Ratio in Severe Acute Pancreatitis Patients

Effects of Ω‐3 Fish Oil Lipid Emulsion Combined with Parenteral Nutrition on Patients Undergoing Liver Transplantation

Effect of Parenteral Fish Oil Lipid Emulsion in Parenteral Nutrition Supplementation Combined with Enteral Nutrition Support in Patients Undergoing Pancreaticoduodenectomy

The Efficacy of Parenteral Fish Oil in Critical Illness Patients with Sepsis: a Prospective, Non-Randomized, Observational Study

Fish Oil-Supplemented Parenteral Nutrition in Severe Acute Pancreatitis Patients and Effects on Immune Function and Infectious Risk: A Randomized Controlled Trial

Liver-protecting Effects of Omega-3 Fish Oil Lipid Emulsion in Liver Transplantation

Impact of Short-Term Omega-3 Fatty Acids Supplementation on Clinical Outcomes in Postoperative Patients with Parenteral Nutrition Support: a Meta-analysis of Randomized Controlled Trials

Effect of postoperative early ω-3 polyunsaturated fatty acid-based total parenteral nutrition on postoperative complications for patients with Crohn′s disease

Cost and Effectiveness of Omega-3 Fatty Acid Supplementation in Chinese ICU Patients Receiving Parenteral Nutrition

The Impact of Fish Oil (Ω-3 Fatty Acids) Intervention on Infectious Complications and Cost-Effectiveness for Postoperative Patients: Systematic Review (2010-2016)

Early Peritoneal Lavage with Ulinastatin Improves Outcome and Enhances Multi-Organ Protection in a Model of Severe Acute Pancreatitis.

IMR880760 Supplemetal Material - Supplemental Material for Effect of Regional Arterial Infusion Combined with Early Enteral Nutrition on Severe Acute Pancreatitis

The Role of Omega-3 Fatty Acids in Acute Pancreatitis: A Meta-Analysis of Randomized Controlled Trials

Omega‐3 fatty acid lipid emulsions are safe and effective in reducing endotoxemia and sepsis in acute‐on‐chronic liver failure: An open‐label randomized controlled trial